BioSpace News Archive

Arrowhead Pharmaceuticals Inc. announced that as an inducement to entering into employment with the Company, on September 13, 2019, the Compensation Committee of the Board of Directors approved “inducement” grants to 17 new employees under Rule 5635 of the NASDAQ Marketplace Rules.

ACADIA Pharmaceuticals Inc. announced the closing of its previously announced underwritten public offering of 7,187,500 shares of its common stock, which includes 937,500 shares of common stock sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a public offering price of $40.00 per share.

Envista Holdings Corporation, a subsidiary of Danaher Corporation (NYSE: DHR), today announced the closing of its previously announced initial public offering (IPO) of 26,768,000 shares of its common stock at a price to the public of $22.00 per share.

PTC Therapeutics, Inc. announced that on September 18, 2019 it approved non-statutory stock options to purchase an aggregate of 211,500 shares of its common stock to 48 new employees.

Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, today announced that it will hold its Annual General Meeting of shareholders (the “Meeting”) on Friday, November 8th, 2019 at 10:00am MT